Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing
Key Findings
Patients with severe symptoms from mid-cavity obstructive hypertrophic cardiomyopathy benefited from personalized pacing (PPoP) with reductions in obstruction and improved exercise performance.
Practical Solutions
Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research for easy access by clinicians. Mobile apps support scheduling, monitoring treatments, and telemedicine, streamlining operations and expanding digital services.
Value
Using AI, clinics can enhance workflows, improve patient outcomes, and reduce paper routines, ultimately advancing everyday medical practice.
